echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Thousands of basic drugs in Beijing aim at the lowest price in China!

    Thousands of basic drugs in Beijing aim at the lowest price in China!

    • Last Update: 2016-07-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: Beijing business daily July 25, 2016 Japan is the deadline for price information update and declaration of over 1000 basic drugs in Beijing Many pharmaceutical companies are still studying this new policy, because according to the new requirements, these drugs must be subject to the lowest bid price in the country, which is interpreted as a signal of great significance After this heavy blow, Beijing drug bidding reform may have a big move Among the drugs that are required to implement the lowest price in China, there are many common drugs such as Bupleurum oral liquid, Xiangsha Yangwei pill and azithromycin capsule Cai Jiangnan, director of the center for health management and Policy Research of CEIBS, said that the basic drugs are widely used, so he often becomes a pathfinder of new drug price regulations Generally speaking, lowering the drug price is conducive to reducing the cost of patients seeing a doctor Pressure, and a more perfect drug price formation mechanism is also conducive to the reform of hierarchical diagnosis and treatment, separation of medicine and other obstacles The national linkage of prices of more than 1000 basic drugs "has no lowest, only lower" On July 14, Beijing Pharmaceutical centralized purchase service center posted a notice on the official website of "price linkage and information update of basic drugs at the grassroots level", with 8 attachments for explanation It is required to declare the price information of multiple basic drugs before the 25th of this month In the following days, the impact of the notice continued to ferment in the pharmaceutical industry "At the beginning, I just thought that this was the notice of bidding for more than 1000 kinds of essential drugs, which didn't attract much attention, but later I found that it was clearly mentioned in the annex that the principle of the lowest bid price in China was adopted before I began to pay attention to it, which was also the most clear statement of Beijing on the low price bidding." Yesterday, a senior executive of a pharmaceutical company told Beijing business daily The so-called "essential drugs" refer to the drugs that can meet the basic medical and health needs, with appropriate dosage forms, guaranteed supply, equipped at the grass-roots level and fair access to by the people The main characteristics are safety, necessity, effectiveness and low price To adopt the lowest price in China, Beijing Medical centralized procurement service center points out that it is based on the principle of "integrating online procurement platform of large hospitals and online procurement platform of community medical and health institutions, realizing the unification of catalogue and procurement" At the same time, it is determined by the measures of deepening medical reform, such as establishing a hierarchical diagnosis and treatment system, promoting the reform of medical separation, and improving the mechanism of medical price adjustment According to the above-mentioned pharmaceutical executives, there are more than 1000 kinds of drugs listed in the price linkage, mainly basic drugs However, at present, Beijing and even Beijing, Tianjin and Hebei are planning to conduct unified bidding for drugs and medical consumables I'm afraid that the price linkage of more than 1000 basic drugs is only the first step It is expected to carry out dynamic price adjustment In view of whether Beijing will implement the national lowest price drug bidding mode in a large scale, the reporter of Beijing business daily contacted the municipal pharmaceutical centralized procurement service center Relevant staff said that the new policy of bidding and procurement has not been officially implemented, so it is inconvenient to be interviewed You can get information from the Beijing Municipal Health and Planning Commission Later, the relevant person in charge of the municipal health and Family Planning Commission said that the content of the published policy shall prevail, and further information will take a long time to understand and communicate According to the value principle of the lowest bidding price in China published on the website of Beijing Medical centralized purchasing service center, including that if there is one or more provincial bidding prices for the newly declared products in Beijing, the bidding price shall not be higher than the lowest bidding price in China Among them, the value of non Beijing current bid winning products shall not be higher than the unit price of products of the same enterprise, the same variety, and different loading specifications / packages of the original Beijing bid winning products For example, if a drug has won the bid in 10 other regions, the lowest bid price of these 10 regions will be directly recognized as the lowest bid price of the product in China The price adopted by Beijing cannot be higher than this price If a drug has not won the bid in other places before, it shall not be higher than the national lowest price of other drugs and the bid price of new drugs shall not be higher than the original bid price "In the policy of adopting the lowest bid price in China, in addition to the price, another new change should be the dynamic adjustment of the price," said Ren Peng, general manager of Beijing Beiwei Pharmaceutical Co., Ltd“ Originally, after winning the bid for a basic drug, the price could be maintained for several years, and it could not be adjusted until the next bidding However, the price linkage proposed this time should be that with the change of the lowest price in China, the price adopted in Beijing will fluctuate as well " In fact, last year, Tianjin Health and Family Planning Commission proposed that we should give full play to the role of the Municipal Drug Centralized procurement platform, collect the lowest bid winning prices in all parts of the country, and implement periodic dynamic adjustment of the bid winning prices in the whole city, and adjust the prices to the lowest in the country in a quarterly cycle However, some pharmaceutical companies have proposed that this increase the uncertainty of pharmaceutical companies participating in the bidding In addition, since it is a linkage price adjustment mechanism, if the cost of drug production increases greatly due to factors such as raw materials, it is not clear whether the bid price can also be raised to a more reasonable price It is hoped that in the process of improving the drug pricing mechanism, the policy can be further refined and issued What we should pay attention to is that many years ago, every hospital and drug production or distribution enterprise in China implemented the decision of purchase price separately However, in order to enter the list of hospital purchase, some small and medium-sized enterprises often give low discount to hospitals or implement rebate policy, which leads to the disorder of drug purchase and sale, high drug price and corruption At present, most of the drugs sold in medical institutions are purchased by the local government through centralized bidding, which solves some disadvantages of the previous industry But on the other hand, the way of drug centralized bidding and purchase is not smooth, and even it was once pointed out that due to the unreasonable evaluation standard, there was the coexistence of virtual high and virtual low drug prices Among them, the "only low price is to take" drug bidding has made many drug enterprises shout, the virtual low bid price is serious, affecting supply and quality So how to avoid these problems has become the focus of the outside world Cai Jiangnan analyzed that because of the large amount of basic drugs used, they are mainly paid by medical insurance, so the price issue is particularly important He further pointed out that "due to the large number of drugs used in Beijing, Shanghai, Guangzhou and other places, we can give full play to the advantages of the integration of bidding and procurement and batch procurement in accordance with the principle of quantity procurement and quantity price linkage That is to say, although the price winning the bid in Beijing is the lowest in China, if the sales volume is large, the pharmaceutical enterprises can also make a reasonable profit However, this model is not suitable for national promotion, because many places with small drug use, if they compare the lowest price blindly, it may affect the enthusiasm of enterprises to participate in the bidding of essential drugs, and it is not conducive to ensuring the quality of drugs " It is also worth noting that in an interview with a reporter from Beijing Business Daily yesterday, relevant staff of many pharmaceutical companies reported that they are now testing new drug bidding policies in many places Some policies are even changing day and night, and enterprises are eager to unify the bidding policies as much as possible and have sustainability.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.